HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 148 | 156 | 94.9% | |
| HF004 | 2020 | 153 | 161 | 95.0% | |
| HF006 | 2021 | 208 | 230 | 90.4% | |
| HF006 | 2022 | 223 | 230 | 97.0% | |
| HF006 | 2023 | 271 | 285 | 95.1% |
